This is our Regulatory Landscape newsletter for April 2026 with our monthly insights on the evolving market for Regulatory professionals. For the month of March, there were 116 new Regulatory positions posted at smaller and mid-sized biopharma companies in the US. This is up 22% from February and up 35% from last March. This is[…]
This is our Regulatory Landscape newsletter for March 2026 with our monthly insights on the evolving market for Regulatory professionals. For the month of February, there were 95 new Regulatory positions posted at smaller and mid-sized biopharma companies in the US. This is down 17% from January but up 15% from last February. 48% of[…]
Dennis Partners conducted our annual survey on Regulatory Career Motivations during the week of February 16, 2026. Since the start of The Great Resignation in 2021, Regulatory Affairs professionals have continued to reassess what matters most in their careers — with flexibility, culture, and long-term stability shaping decision-making now more than ever. To understand how[…]
This is our Regulatory Landscape newsletter for February 2026 with our monthly insights on the evolving market for Regulatory professionals. The market definitely seems to be improving from last year. For the month of January, there were a whopping 114 new Regulatory positions posted at smaller and mid-sized biopharma companies in the US. This is[…]
Happy New Year and I hope you all enjoyed the holidays! This is our Regulatory Landscape newsletter for January 2026 with our monthly insights on the evolving market for Regulatory professionals. For the month of December there were 73 new Regulatory positions posted at smaller and mid-sized biopharma companies in the US. This is down[…]
This is our Regulatory Landscape newsletter for October 2025 with our monthly insights on the evolving market for Regulatory professionals. For the month of September there were 74 new Regulatory positions posted at smaller and mid-sized biopharma companies in the US. This is down 9.7% from August and down 15% from last September. 61% of[…]
The regulatory affairs community is facing a new wave of uncertainty following recent layoffs at key federal agencies, including the FDA, NIH, HHS, and CDC. Last week, we surveyed regulatory affairs professionals across the pharmaceutical and biotech industries to assess the impact of these recent layoffs. Our goal was to understand how these changes are[…]
This is our Regulatory Landscape newsletter for April 2025 with our monthly insights on the evolving market for Regulatory professionals. For the month of March there were approximately 86 new Regulatory positions posted at smaller biopharma companies in the US. This is up about 3% from February but down 8.5% from what we saw in[…]
Dennis Partners conducted our latest survey on Regulatory Career Motivations during the week of February 23, 2025. Since the start of The Great Resignation in 2021, employees have continued to reassess their careers, with remote work, compensation, and company culture playing pivotal roles in job decisions. To understand how Regulatory Affairs professionals feel about their[…]
Pay transparency is coming to the biopharma industry. In fact, there’s already some form of law in place in California, Colorado, Connecticut, Maryland, and Washington with new transparency laws enacting in New York on November 1, 2022. Job boards such as Indeed are seeing an increase in companies sharing salary ranges. LinkedIn’s latest Workforce Confidence[…]
